Hatch Waxman > Nova Content
Written by Marc Chatenay-Lapointe, Ph.D. and Jing Liu, Ph.D.
On March 13, 2017, the use of Novartis cell cycle inhibitor Kisqali® (ribociclib, LEE011) in... Read More »
Written by Daniel K. Yarbrough, Ph.D. and Kerry S. Taylor, Ph.D.
Bevacizumab (Avastin®) is the subject of the widely watched “patent dance”... Read More »
Market intelligence is especially critical to sound pharmaceutical investing
Pharmaceutical investing is both challenging and potentially very rewarding, but it... Read More »
Written by Mark E. Davis and Kerry S. Taylor, Ph.D.
The PTAB issued two final written decisions upholding The University of Pennsylvania’s claims to methods ... Read More »
Written by Sabrina Wang and Adam Powell
The Federal Circuit held that a rat study in a provisional application and a conversion method in an uncited reference did ... Read More »
Written by Kerry S. Taylor, Ph.D. and Nathanael Luman, Ph.D.
The PTAB issued a Final Written Decision upholding Pozen’s ulcer reducing Vimovo® claims... Read More »
Written by Caleb A. Bates, Ph.D. and Agnes Juang, Ph.D.
On January 12, 2017, the U.S. Court of Appeals for the Federal Circuit issued an opinion affirming the... Read More »
By Barry Herman
By now, most everyone in the patent community has heard about the $2.54 Billion dollar jury verdict in a battle over Hepatitis C medication that... Read More »
Written by Marc Chatenay-Lapointe, Ph.D. and Michael L. Fuller
On December 23, 2016, the U.S. Food and Drug Administration approved SPINRAZA™ (nusinersen)... Read More »
Written by Eric S. Furman, Ph.D. and Caleb A. Bates, Ph.D.
On November 21, 2016, the U.S. Court of Appeals for the First Circuit upheld a 2014 jury verdict for... Read More »
The size of businesses sued most frequently for patent infringement in 2016 were significantly larger than in 2015, when five little-known patent holders were among... Read More »
Currently there are two competing patent reform bills making the rounds in Congress: Representative Goodlatte’s Innovation Act of 2015 and the Strong Patent Act ... Read More »
Penicillin, teflon, plastic, and now nanoparticles; all breakthrough discoveries stemming from scientific “failures.” University of Central Florida... Read More »
In... and out. In... and out. Air flows through the narrow channel carved into the small silicon chip, blood pumping, the miniature lung embedded inside breaths... Read More »
Mobile health apps are developing quickly, and they aim to replace and/or complement treatments prescribed by doctors. The newest app on the block is Happitique. This ... Read More »
Here’s the top medical news of this week!
Promising new HIV treatments give hope for eventual cure
The Human Immunodeficiency Virus (HIV)... Read More »
This week, Roche announced it has discontinued development of its cholesterol drug dalcetrapib, marking the end of the story for a drug once touted as a potential... Read More »
Here's your weekly roundup of hot medical news...
Kidney transplant breakthroughs
For the first time, a kidney that had been donated to... Read More »
Technological advancement has revolutionized manufacturing procedures. One of the most talked about advancements in manufacturing is 3D printing. 3D printing not only ... Read More »
If you are one of the 48 percent of Americans that took a prescription drug in the past month, you probably read through a litany of potential side effects attributed ... Read More »